back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-10-26 Tx date 2018-03-01 |
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Rolfes, Patrick
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+750,000 vol |
750,000 | |
| Filed 2018-10-26 Tx date 2018-05-03 |
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Rolfes, Patrick
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+61,647 vol |
841,410 | |
| Filed 2018-10-26 Tx date 2018-03-01 |
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Rolfes, Patrick
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-26 Tx date 2018-03-31 |
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Rolfes, Patrick
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+29,763 vol |
779,763 | |
| Filed 2018-10-26 Tx date 2018-06-06 |
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Rolfes, Patrick
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+96,060 vol |
937,470 |